About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
https://www.weizmann-usa.org/news-media/news-releases/plant-research-reaches-a-new-high/
Apr 30, 2023... REHOVOT, ISRAEL—May 1, 2023—A South African plant called a woolly umbrella is completely unrelated to the cannabis plant, yet it makes a slew of the active compounds found in cannabis – cannabinoids – including some that may have new medical uses. In a study published today in Nature Plants, Weizmann Institute of Science researchers identified more than 40 cannabinoids in the woolly umbrella, and they revealed the series of biochemical steps the plant takes when it makes these compounds. The researchers also showed how these steps can be reproduced in the lab to synthesize or even engineer new cannabinoids.
Aug 07, 2023...
REHOVOT, ISRAEL — August 8, 2023—Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that allow them to evade the medications’ therapeutic effect.
In research published today in the journal Cell Reports Medicine, investigators from the Weizmann Institute of Science report findings that may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists identified a biomarker that may help physicians treat select lung cancer patients with a single antibody-based drug that is likely to bring about full remission, without cancer relapse.
Sep 06, 2023... Scientists grow whole model of human embryo, without sperm or egg
Sep 07, 2023... Lab-grown human "embryo-like structures" bring hope for research into early-pregnancy complications
https://www.weizmann-usa.org/news-media/feature-stories/evolutionary-safety-first/
Feb 21, 2024... At the height of the coronavirus pandemic, pharmaceutical company Merck received emergency, fast-track approval from the USDA for a new drug called molnupiravir, which tricks the SARS-CoV-2 virus into mutating so quickly that it kills itself off. One social media user’s logical response to the news got the attention of Prof. Yitzhak Pilpel in Weizmann’s Molecular Genetics Department: Could humans encounter more dangerous strains of coronavirus and end up paying a heavy price for this innovation?
Mar 26, 2024...
Jerusalem, March 26, 2024 – The Blavatnik Family Foundation, the Israel Academy of Sciences and Humanities and The New York Academy of Sciences announced today the Laureates of the 2024 Blavatnik Awards for Young Scientists in Israel. This year’s Laureates, who will each receive $100,000, are:
Schraga Schwartz, PhD (Life Sciences) – Weizmann Institute of Science – Recognized for developing groundbreaking analytical methods to locate and quantify chemical changes in RNA. Professor Schwartz’s breakthroughs in understanding RNA modifications hold promise for treating genetic diseases and expanding the role of RNA editing beyond vaccine development.